NDC11 65757030202
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 65757-0302-02 | 65757-0302 |
| 65757-0302-2 | 65757-0302 |
| 65757-302-02 | 65757-302 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VIVITROL | NALTREXONE | Alkermes, Inc. | cd11c435-b0f0-4bb9-ae78-60f101f3703f | 2026-05-31 | Warnings, Adverse reactions | 65757-302-02 65757030202 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.